BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 12773120)

  • 1. Insulin inhibition of the proteasome is dependent on degradation of insulin by insulin-degrading enzyme.
    Bennett RG; Fawcett J; Kruer MC; Duckworth WC; Hamel FG
    J Endocrinol; 2003 Jun; 177(3):399-405. PubMed ID: 12773120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin acts intracellularly on proteasomes through insulin-degrading enzyme.
    Duckworth WC; Bennett RG; Hamel FG
    Biochem Biophys Res Commun; 1998 Mar; 244(2):390-4. PubMed ID: 9514933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the insulin inhibition of the peptidolytic activities of the insulin-degrading enzyme-proteasome complex.
    Bennett RG; Hamel FG; Duckworth WC
    Diabetes; 1997 Feb; 46(2):197-203. PubMed ID: 9000694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin inhibits the ubiquitin-dependent degrading activity of the 26S proteasome.
    Bennett RG; Hamel FG; Duckworth WC
    Endocrinology; 2000 Jul; 141(7):2508-17. PubMed ID: 10875252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin and analogue effects on protein degradation in different cell types. Dissociation between binding and activity.
    Fawcett J; Hamel FG; Bennett RG; Vajo Z; Duckworth WC
    J Biol Chem; 2001 Apr; 276(15):11552-8. PubMed ID: 11116143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of multicatalytic enzyme activity by insulin and the insulin-degrading enzyme.
    Hamel FG; Bennett RG; Duckworth WC
    Endocrinology; 1998 Oct; 139(10):4061-6. PubMed ID: 9751483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A direct inhibitory effect of insulin on a cytosolic proteolytic complex containing insulin-degrading enzyme and multicatalytic proteinase.
    Duckworth WC; Bennett RG; Hamel FG
    J Biol Chem; 1994 Oct; 269(40):24575-80. PubMed ID: 7929129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Degradation of amylin by insulin-degrading enzyme.
    Bennett RG; Duckworth WC; Hamel FG
    J Biol Chem; 2000 Nov; 275(47):36621-5. PubMed ID: 10973971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide inhibits insulin-degrading enzyme activity and function through S-nitrosylation.
    Cordes CM; Bennett RG; Siford GL; Hamel FG
    Biochem Pharmacol; 2009 Mar; 77(6):1064-73. PubMed ID: 19154729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redox regulation of insulin degradation by insulin-degrading enzyme.
    Cordes CM; Bennett RG; Siford GL; Hamel FG
    PLoS One; 2011 Mar; 6(3):e18138. PubMed ID: 21448434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Degradation of relaxin family peptides by insulin-degrading enzyme.
    Bennett RG; Heimann DG; Hamel FG
    Ann N Y Acad Sci; 2009 Apr; 1160():38-41. PubMed ID: 19416156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ubiquitin-proteasome-dependent muscle proteolysis responds slowly to insulin release and refeeding in starved rats.
    Kee AJ; Combaret L; Tilignac T; Souweine B; Aurousseau E; Dalle M; Taillandier D; Attaix D
    J Physiol; 2003 Feb; 546(Pt 3):765-76. PubMed ID: 12563002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and isolation of a cytosolic proteolytic complex containing insulin degrading enzyme and the multicatalytic proteinase.
    Bennett RG; Hamel FG; Duckworth WC
    Biochem Biophys Res Commun; 1994 Jul; 202(2):1047-53. PubMed ID: 8048917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ubiquitin-proteasome proteolytic pathway in heart vs skeletal muscle: effects of acute diabetes.
    Liu Z; Miers WR; Wei L; Barrett EJ
    Biochem Biophys Res Commun; 2000 Oct; 276(3):1255-60. PubMed ID: 11027619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Degradation of methoxysuccinyl-phe-leu-phe-7-amido-4-trifluoromethyl coumarin (FLF) in cultured myotubes and HepG2 cells is proteasome- and calpain/calcium-dependent.
    Li BG; Fang CH; Hasselgren P
    Int J Biochem Cell Biol; 2000 Jun; 32(6):677-86. PubMed ID: 10785364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in the cellular processing of AspB10 human insulin compared with human insulin and LysB28ProB29 human insulin.
    Hamel FG; Siford GL; Fawcett J; Chance RE; Frank BH; Duckworth WC
    Metabolism; 1999 May; 48(5):611-7. PubMed ID: 10337862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of nelfinavir on insulin metabolism, proteasome activity and protein degradation in HepG2 cells.
    Hamel FG; Fawcett J; Tsui BT; Bennett RG; Duckworth WC
    Diabetes Obes Metab; 2006 Nov; 8(6):661-8. PubMed ID: 17026490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the inhibition of protein degradation by insulin in L6 cells.
    Fawcett J; Hamel FG; Duckworth WC
    Arch Biochem Biophys; 2001 Jan; 385(2):357-63. PubMed ID: 11368017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endoplasmic reticulum-localized amyloid beta-peptide is degraded in the cytosol by two distinct degradation pathways.
    Schmitz A; Schneider A; Kummer MP; Herzog V
    Traffic; 2004 Feb; 5(2):89-101. PubMed ID: 14690498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The balance between glucocorticoids and insulin regulates muscle proteolysis via the ubiquitin-proteasome pathway.
    Bailey JL; Wang X; Price SR
    Miner Electrolyte Metab; 1999; 25(4-6):220-3. PubMed ID: 10681643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.